https://www.selleckchem.com/pr....oducts/diphenyleneio
96]) and all forms of CRN. However, when the number of unique medications was added to the model, there were no statistically significant differences in CRN between the two groups. Older adults with ACO represent a vulnerable population with increased risk for CRN. Multiple factors can contribute to CRN including a higher number of prescribed medications, multiple co-morbidities, and cost of therapies. Medication comprehensive review interventions have the potential of reducing the risk of CRN among the older Me
Like
Comment
Share
